|
| Exchange Received Time 28/04/2018 21:51:15 Exchange Disseminated Time 28/04/2018 21:51:22 Time Taken 00:00:07 | Our Board of Directors at their meeting held today, approved the Audited Financial Results (Stand-alone and Consolidated) for the FY ended 31-03-2018 and have decided to recommend final dividend at the rate of Rs. 5.00 per share The Meeting concluded at 8.15 p.m. today.
The Board also approved granting of Stock Options to eligible employees for 2017-18 subject to approval by Members, and giving a loan upto Rs.100 crores to the wholly owned subsidiary, Nueclear Healthcare Ltd., for business expansion.
Pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulations, 2015, the following are filed separately.
1. Stand-alone and Consolidated Audited Financial Results for the quarter and the financial year ended March 31, 2018, and the Auditors' Reports thereon.
The statutory auditors have issued unmodified opinion on both the Stand-alone and Consolidated Financial Results.
|
|
|